Information  X 
Enter a valid email address

Anpario PLC (ANP)


Friday 16 October, 2020

Anpario PLC

Lady Oregon Goes Aloft

RNS Number : 3707C
Anpario PLC
16 October 2020

Anpario plc ("Anpario")

Lady Oregon Goes Aloft


Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is pleased to announce that the racing pigeon called Lady Oregon recently won the famous Sydney Gold Ring Race. Lady Oregon, who was raised on Orego-Stim® liquid in her drinking water every day, has been a consistent winner in various races around Australia. However, the Sydney Gold Ring Race is one of the richest long-distance endurance races which starts from Byrock in New South Wales. Approximately 565km, the pigeons fly in a westerly direction to Sydney. Prize money for the winner is AUD$13,500 plus a gold ring valued at AUD$3,500.


Orego-Stim® is Anpario's leading phytogenics product which through improving gut health maximises immune levels and supports a quicker recovery from racing. Produced from natural and sustainable oregano sources Orego-Stim® is used in many other animal health applications including poultry, swine, dairy and aquaculture. Pigeon racing is big business. A Chinese fancier paid £1.1m for Belgian Champion Armando last year and owners are keen to boost their chances of winning by using Orego-Stim®. Lady Oregon's average speed was 84km/hour against a headwind gusting 30-40km/hour and she landed almost an hour before the runner-up.




Anpario plc
Richard Edwards, Chief Executive Officer    +44(0) 777 6417 129
Karen Prior, Group Finance Director                         +44(0) 1909 537380



This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t